Frequently Asked Questions
The market is segmented based on , By Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Oncology Nutrition Market size was valued at USD 1974.75 USD Million in 2022.
The Global Oncology Nutrition Market is projected to grow at a CAGR of 7.91% during the forecast period of 2023 to 2030.
The major players operating in the market include FMC Corporation, Danone, Abbott, Aceto, B. Braun Melsungen AG, Baxter, Fresenius Kabi AG, Global Health Products , Hormel Foods Corporation, Mead Johnson & Company LLC, Meiji Holdings Co. Ltd, Nestlé S.A., BioSig Technologies , Auris Health
.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
